DAY ONE BIOPHARMACEUTICALS

EUIPO EUIPO 2024 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark DAY ONE BIOPHARMACEUTICALS was filed as Word mark on 02/24/2024 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/05/2024. The current status of the mark is "Trademark registered".

Trademark Details Last update: Today

Trademark form Word mark
File reference 018990457
Application date February 24, 2024
Publication date March 28, 2024
Entry date July 5, 2024
Expiration date February 24, 2034

Trademark owner

2000 Sierra Point Parkway, Suite 501
94005 Brisbane, CA
US

Trademark representatives

2 Dublin Landings, North Wall Quay Dublin 1 IE

goods and services

5 Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; targeted medical preparations for use in the field of cancer prevention and treatment; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
42 Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders
44 Medical information services; healthcare services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders; healthcare services, namely, wellness and disease management programs; providing clinical information and support services regarding prescription drugs and treatment of disease; providing medical information regarding the treatment, and diagnosis of diseases; healthcare patient support services by means of a call center; providing patient support services, namely, providing patient check-up services in the form of reminders, wellness trackers, and patient and caregiver wellness check-ups; providing a website featuring health information in the field of tumors and cancer

ID: 11018990457